ArticleThe Eurasian journal of medicine2026
Relationship Between Hemoglobin, Serum Iron, Iron-Binding Capacity, Ferritin, Zinc, Vitamin B12, and Vitamin D Levels in Patients with Melasma and the Severity of Their Condition.
Article in The Eurasian journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMelasma is an acquired disease with an unclear etiology. This study aimed to compare the hemoglobin, serum iron, iron-binding capacity, ferritin, zinc, vitamin B12, and vitamin D levels in patients with melasma to those in controls and to investigate a possible relationship between these parameters and melasma severity.
methodsOne hundred consecutive patients with melasma and 50 healthy controls were included in this case-control observational study. Demographic features and disease duration were recorded. Melasma lesions were scored according to the melasma area severity index (MASI). Hemoglobin, serum iron, total iron binding capacity (TIBC), ferritin, vitamin D, vitamin B12, and zinc levels were compared between patients and controls. Possible correlations between these parameters and the MASI were also investigated.
resultsIn terms of laboratory data, there were statistically significant differences in hemoglobin, vitamin D, ferritin, and TIBC between melasma patients and the control group, but no statistically significant difference was observed in vitamin B12, zinc, and iron levels. A statistically significant positive correlation was found between the MASI score, age, melasma disease duration, and ferritin.
conclusionThe study presented lower hemoglobin, vitamin D, and ferritin levels in patients with melasma than in controls and demonstrated a relationship between lower ferritin levels and melasma severity. Considerations of these deficiencies may contribute to the holistic approach to melasma. Cite this article as: Akal E, Melikoglu M. Relationship between hemoglobin, serum iron, iron-binding capacity, ferritin, zinc, vitamin B12, and vitamin D levels in patients with melasma and the severity of their condition. Eurasian J Med. 2026, 58(3), 1291, doi: 10.5152/eurasianjmed.2026.251291.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.